Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case–control comparison with patients testing negative
Journal article
Luykx JJ. et al, (2024), The Lancet Psychiatry, 11, 828 - 838
Supporting people in Early Intervention in Psychosis services: the role of primary care.
Journal article
Chew-Graham C. et al, (2024), Br J Gen Pract, 74
Does the evidence now suggest we can safely reduce the frequency of haematological monitoring for patients stabilised on clozapine?
Journal article
Fanshawe JB. and Lennox BR., (2024), Lancet Psychiatry
Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders - An individual patient data meta-analysis.
Journal article
Campana M. et al, (2024), Brain Behav Immun
Comparing interventions for early psychosis: a systematic review and component network meta-analysis.
Journal article
Williams R. et al, (2024), EClinicalMedicine, 70
Collaboration across the primary/specialist interface in early intervention in psychosis services: a qualitative study.
Journal article
Rickett MC. et al, (2024), Br J Gen Pract
Approaches and challenges to assessing risk of violence in first episode psychosis: A qualitative interview study of clinicians, patients and carers.
Journal article
Whiting D. et al, (2024), Early Interv Psychiatry
CLEAR - clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings.
Journal article
Casetta C. et al, (2024), BMC Psychiatry, 24
Effectiveness of participatory video in lowering stigma against people with mental, neurological and substance use disorders in Kenya.
Journal article
Bitta MA. et al, (2023), BJPsych Open, 9
Psycho-pharmacomicrobiomics: A Systematic Review and Meta-analysis.
Journal article
Minichino A. et al, (2023), Biol Psychiatry
Predictors of positive patient-reported outcomes from 'Early Intervention in Psychosis': a national cross-sectional study.
Journal article
Williams R. et al, (2023), BMJ Ment Health, 26
Improving our Understanding of Early Psychosis: Learning from the Optimise Trial.
Journal article
Lennox B., (2023), Schizophr Bull, 49, 829 - 830
Assessing violence risk in first-episode psychosis: external validation, updating and net benefit of a prediction tool (OxMIV).
Journal article
Whiting D. et al, (2023), BMJ Ment Health, 26
What happens after early intervention? Mapping early intervention in psychosis care pathways in the 12 months after discharge.
Journal article
Puntis S. et al, (2023), Early Interv Psychiatry
Predictors of positive outcomes from ‘Early Intervention in Psychosis’: protocol for a national retrospective cohort study
Journal article
Williams R. et al, (2023), Frontiers in Psychiatry, 14
The serum metabolomic profile of a distinct, inflammatory subtype of acute psychosis.
Journal article
Lennox B. et al, (2022), Mol Psychiatry
Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis.
Journal article
Al-Diwani A. et al, (2022), Brain, 145, 2742 - 2754
Investigating the pro-cognitive and anti-depressant efficacy of metformin: A systematic review and meta-analysis of randomised controlled trials.
Journal article
Nibber A. et al, (2022), J Affect Disord, 310, 52 - 59
Time to re-evaluate the risks and benefits of valproate and a call for action.
Journal article
Howes OD. et al, (2022), Br J Psychiatry, 1 - 3
The early impact of the COVID-19 pandemic on patients with severe mental illness: An interrupted time series study in South-East England
Journal article
Penington E. et al, (2022), European Psychiatry